Hospital Universitario Príncipe de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2017

  1. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications

    Cytometry Part B - Clinical Cytometry, Vol. 92, Núm. 5, pp. 361-370

2016

  1. Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

    Leukemia Research, Vol. 40, pp. 1-9

2010

  1. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

    Journal of Allergy and Clinical Immunology, Vol. 125, Núm. 6

2006

  1. Accurate apoptosis measurement requires quantification of loss of expression of surface antigens and cell fragmentation

    Cytometry Part A, Vol. 69, Núm. 4, pp. 240-248

2004

  1. Loss of lineage antigens is a common feature of apoptotic lymphocytes

    Journal of Leukocyte Biology, Vol. 76, Núm. 3, pp. 609-615

2002

  1. Apoptotic rate: A new indicator for the quantification of the incidence of apoptosis in cell cultures

    Cytometry, Vol. 48, Núm. 4, pp. 185-193

2000

  1. A new method for the simultaneous analysis of growth and death of immunophenotypically defined cells in culture

    Cytometry, Vol. 39, Núm. 1, pp. 56-66